Eli Lilly (LLY) Long-Term Debt Issuances (2016 - 2025)
Historic Long-Term Debt Issuances for Eli Lilly (LLY) over the last 12 years, with Q3 2025 value amounting to $6.7 billion.
- Eli Lilly's Long-Term Debt Issuances rose 3508.04% to $6.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $13.2 billion, marking a year-over-year increase of 1532.88%. This contributed to the annual value of $11.4 billion for FY2024, which is 18841.99% up from last year.
- Eli Lilly's Long-Term Debt Issuances amounted to $6.7 billion in Q3 2025, which was up 3508.04% from $6.5 billion recorded in Q1 2025.
- In the past 5 years, Eli Lilly's Long-Term Debt Issuances registered a high of $6.7 billion during Q3 2025, and its lowest value of $2.4 billion during Q3 2021.
- Its 4-year average for Long-Term Debt Issuances is $5.2 billion, with a median of $5.7 billion in 2024.
- As far as peak fluctuations go, Eli Lilly's Long-Term Debt Issuances surged by 12453.2% in 2021, and later grew by 13.17% in 2025.
- Over the past 4 years, Eli Lilly's Long-Term Debt Issuances (Quarter) stood at $2.4 billion in 2021, then surged by 64.2% to $4.0 billion in 2023, then rose by 25.42% to $5.0 billion in 2024, then surged by 35.08% to $6.7 billion in 2025.
- Its Long-Term Debt Issuances was $6.7 billion in Q3 2025, compared to $6.5 billion in Q1 2025 and $5.0 billion in Q3 2024.